Our results confirmed a high level of concordance between IHC and FISH methodologies to assess HER2 status in gastric cancer, as previously reported by other authors (Takehana et al, 2002; Yano et al, 2006; Hofmann et al, 2008; Marx et al, 2009). This evidence concerns the gene ERBB2 and gastric cancer.